TAVT-45
-
King of Prussia Pharma Company Enters Phase Three for Easy-to-Consume Prostate Treatment
Tavanta Therapeutics, King of Prussia, has reached phase three of clinical trials associated with TAVT-45, a pipeline of specialty drugs…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
